Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CellSource Co., Ltd. ( (JP:4880) ) just unveiled an announcement.
CellSource Co., Ltd. has announced the termination of a stock transfer option agreement involving its major shareholder and former CEO, Takashi Sawada, effective December 15, 2025. This decision follows a transition in the company’s management structure, with Mr. Sawada moving to the role of Chairman of the Board and set to retire in January 2026. The termination reflects a shift in the company’s strategic focus and the altered purpose of the original agreement, aiming to align with the new management’s objectives.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen547.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
Average Trading Volume: 80,833
Technical Sentiment Signal: Sell
Current Market Cap: Yen8.62B
For a thorough assessment of 4880 stock, go to TipRanks’ Stock Analysis page.